Concord Medical Services Holdings

CCM

The current Concord Medical Services Holdings (CCM) market capitalization is approximately $16.76M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Concord Medical Services Holdings's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:25 PM Eastern Time

In the most recently reported quarter, Concord Medical Services Holdings (CCM) generated $14.00M in revenue, representing a -7.00% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: December 31, 2025 at 7:01 PM Eastern Time

In the most recently reported fiscal year, Concord Medical Services Holdings (CCM) generated net income of $-42.23M, compared with $-41.98M in the prior fiscal year, representing a -0.60% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: December 31, 2025 at 7:01 PM Eastern Time

According to its latest quarterly filing, Concord Medical Services Holdings (CCM) reported EBITDA of $-5.87M, representing a +38.34% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: December 31, 2025 at 7:01 PM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 2.22x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: December 31, 2025 at 7:01 PM Eastern Time

Based on the latest available data, Concord Medical Services Holdings (CCM) is currently trading at a last twelve months (LTM) P/E ratio of -0.74x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: December 31, 2025 at 7:01 PM Eastern Time

In the most recently reported quarter, Concord Medical Services Holdings (CCM) revenue was $14.00M. Earnings per share (EPS) for the quarter were $-0.44. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: December 31, 2025 at 7:01 PM Eastern Time

Concord Medical Services Holdings (CCM) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: December 31, 2025 at 7:01 PM Eastern Time

Based on the latest available analyst coverage, Concord Medical Services Holdings (CCM) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: December 31, 2025 at 7:01 PM Eastern Time

Like other publicly traded stocks, Concord Medical Services Holdings (CCM) shares are bought and sold on stock exchanges such as NYSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Concord Medical Services Holdings (CCM) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add CCM to your watchlist.

Concord Medical Services Holdings trades under the ticker symbol CCM on the NYSE stock exchange. The ticker CCM is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Concord Medical Services Holdings (CCM) employs approximately 595 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:25 PM Eastern Time

Concord Medical Services Holdings (CCM) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Concord Medical Services Holdings (CCM) stock peers based on overlapping products, services, and competitive dynamics:EuroEyes International Eye Clinic (1846)Human Health Holdings (1419)Liaoning He Eye Hospital Group (301103)Town Health International Medical Group (3886)FALCO HOLDINGS (4671) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Concord Medical Services Holdings.